Filing Details

Accession Number:
0001209191-10-016220
Form Type:
5
Zero Holdings:
No
Publication Time:
2010-03-11 12:00:00
Reporting Period:
2009-12-31
Filing Date:
2010-03-11
Accepted Time:
2010-03-11 13:06:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1389870 Omni Bio Pharmaceutical Inc. OMBP Biological Products, (No Disgnostic Substances) (2836) 208097969
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1377756 Boco Investments Llc 262 East Mountain Ave.
Fort Collins CO 80524
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Acquisiton 2009-03-31 1,450,000 $0.10 1,800,000 No 4 P Direct
Common Acquisiton 2009-03-31 250,000 $0.20 1,800,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrants Acquisiton 2009-03-31 725,000 $0.00 725,000 $0.25
Common Stock Warrants Acquisiton 2009-03-31 209,892 $0.00 209,892 $0.50
Common Stock Warrants Acquisiton 2009-03-31 2,690,108 $0.00 2,690,108 $0.50
Common Stock Warrants Acquisiton 2009-03-31 1,450,000 $0.00 1,450,000 $1.00
Common Stock Warrants Acquisiton 2009-03-31 100,000 $0.00 100,000 $0.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
725,000 2009-03-31 2013-12-31 No 4 P Direct
209,892 2009-03-31 2013-12-31 No 4 P Direct
2,690,108 2013-12-31 No 4 P Direct
1,450,000 2013-12-31 No 4 P Direct
100,000 2009-03-31 2013-12-31 No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common 612,000 Indirect LLC
Footnotes
  1. Becomes exercisable to the extent that such exercise or conversion would not result in aggregate beneficial ownership of greater than 19.99%.